Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)

13.32
Delayed Data
As of Apr 06
 +0.21 / +1.62%
Today’s Change
5.70
Today|||52-Week Range
19.00
+22.54%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Arcturus Therapeutics Holdings Inc have a median target of 24.00, with a high estimate of 32.00 and a low estimate of 18.00. The median estimate represents a +80.18% increase from the last price of 13.32.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Arcturus Therapeutics Holdings Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.59
Sales
$5.8M
Reporting Date
May 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 22.86%
 
 
 
 
 
 
Growthannually -30.00%
 
 
 
 
 
 

Sales

Growthquarterly 94.76%
 
 
 
 
 
 
Growthannually -24.88%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.